By Josh White
Date: Monday 18 Nov 2019
(Sharecast News) - Rare and orphan drug consulting services provider Open Orphan announced the signing of a contract with Carna Bioscience for a first-in-human clinical pharmacology trial, it announced on Monday.
By Josh White
Date: Monday 11 Nov 2019
(Sharecast News) - Europe-focussed rare and orphan drug consulting services platform Open Orphan announced the signing of a preferred partner agreement with Ipsen Group on Monday.
By Josh White
Date: Tuesday 15 Oct 2019
(Sharecast News) - Europe-focussed rare and orphan drug consulting services platform provider Open Orphan has signed a new strategic collaboration agreement with Empiric Logic, it announced on Tuesday, to build on the earlier work it had performed, and complete the build out of its 'Health Data' platform as Europe's first rare disease, advocacy-led genomic database.
Currency | UK Pounds |
Share Price | 5.78p |
Change Today | -0.075p |
% Change | -1.28 % |
52 Week High | 8.00 |
52 Week Low | 1.55 |
Volume | 904,893 |
Shares Issued | 254.03m |
Market Cap | £14.67m |
Beta | 0.26 |
RiskGrade | 194 |
Value | ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:10 | 370,000 @ 5.75p |
16:26 | 100,000 @ 5.80p |
15:13 | 38,655 @ 5.80p |
15:13 | 43,103 @ 5.80p |
15:10 | 100,000 @ 5.80p |
COO | Christian Bernard Milla |
CEO | Cathal Friel |
You are here: research